MR Imaging-based Biomarker Development in Hemorrhagic Stroke Patients Including Brain Iron Quantification, Diffusion Tensor Imaging, and Phenomenon of Ultra-early Erythrolysis

Neuroimaging Clin N Am. 2024 May;34(2):215-224. doi: 10.1016/j.nic.2024.01.001. Epub 2024 Feb 10.

Abstract

This review article discusses the role of MR imaging-based biomarkers in understanding and managing hemorrhagic strokes, focusing on intracerebral hemorrhage (ICH) and aneurysmal subarachnoid hemorrhage. ICH is a severe type of stroke with high mortality and morbidity rates, primarily caused by the rupture of small blood vessels in the brain, resulting in hematoma formation. MR imaging-based biomarkers, including brain iron quantification, ultra-early erythrolysis detection, and diffusion tensor imaging, offer valuable insights for hemorrhagic stroke management. These biomarkers could improve early diagnosis, risk stratification, treatment monitoring, and patient outcomes in the future, revolutionizing our approach to hemorrhagic strokes.

Keywords: Early and late brain injury; Early erythrolysis; Hematomal and perihematomal iron concentration; ICH; Iron toxicity; MR imaging biomarkers; SAH; White matter injury.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Brain / diagnostic imaging
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / diagnostic imaging
  • Diffusion Tensor Imaging
  • Hemorrhagic Stroke*
  • Humans
  • Iron
  • Magnetic Resonance Imaging
  • Stroke* / diagnostic imaging

Substances

  • Iron
  • Biomarkers